<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/63A7C928-3A19-4C14-812F-370961534DAC"><gtr:id>63A7C928-3A19-4C14-812F-370961534DAC</gtr:id><gtr:name>John Innes Centre</gtr:name><gtr:department>Contracts Office</gtr:department><gtr:address><gtr:line1>Norwich Research Park</gtr:line1><gtr:line2>Colney</gtr:line2><gtr:line3>Norwich</gtr:line3><gtr:line4>Norwich</gtr:line4><gtr:postCode>NR4 7UH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/63A7C928-3A19-4C14-812F-370961534DAC"><gtr:id>63A7C928-3A19-4C14-812F-370961534DAC</gtr:id><gtr:name>John Innes Centre</gtr:name><gtr:address><gtr:line1>Norwich Research Park</gtr:line1><gtr:line2>Colney</gtr:line2><gtr:line3>Norwich</gtr:line3><gtr:line4>Norwich</gtr:line4><gtr:postCode>NR4 7UH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/2AE83E7A-562E-4E2A-94BC-293AAC6D8E81"><gtr:id>2AE83E7A-562E-4E2A-94BC-293AAC6D8E81</gtr:id><gtr:firstName>Barrie</gtr:firstName><gtr:surname>Wilkinson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BBS%2FE%2FJ%2F000C0665"><gtr:id>7F0F5A12-5A40-4AFA-BDAA-DC64E3051728</gtr:id><gtr:title>Molecular genetics, chemical biology and industrial applications of microbial natural products</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>BBS/E/J/000C0665</gtr:grantReference><gtr:abstractText>Building on JIC?s international reputation in the molecular genetics of actinomycete natural products biosynthesis we will develop new tools &amp;amp; techniques for their discovery and manipulation. Particular areas of expertise include polyketide, non-ribosomal peptide &amp;amp; deoxyhexose pathways, and we aim to identify and delineate new biosynthetic mechanisms and enzymology.
 
 Our approach is two-fold: first to harness known but neglected compounds with potential as anti-infective agents, both anti-proliferative and through the modulation of virulence factors. Secondly, novel compounds have been accessed through our industry contacts and we will expand our interests to identify their molecular targets and mode of action. In all cases we will use bioengineering principles to enable their production for testing and modify their properties to address limitations or enhance properties as required.
 
 Where possible we shall look to target compounds with potential to address diseases that represent emerging public health threats and to these ends will develop our existing collaboration with the Health Protection Agency and the Defence Science and Technology Laboratory. Examples include bacteria such as Legionella, Burkholderia and Mycobacterium tuberculosis, and emerging viruses such as the coronaviruses (e.g. SARS-like coronavirus).
 
 Long term we will expand efforts to incorporate the discovery of natural products which modulate the transcription and translation of key protein targets involved in longevity in model systems. This should be instructive towards understanding the biology of healthy aging as well as the mechanisms of diseases of aging. Natural products have proven fruitful in this arena, e.g. rapamycin &amp;amp; resveratrol. We will build upon an existing collaboration with the Buck Institute of Aging Research in California, and have already identified novel pharmacologic agents that extend the lifespan of model organisms such as yeast and worms</gtr:abstractText><gtr:fund><gtr:end>2017-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2013-06-01</gtr:start><gtr:type>EXPENDITURE_PROJECTED</gtr:type><gtr:valuePounds>718576</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">BBS/E/J/000C0665</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>